- CIGB-300: A Promising Anti-Casein Kinase 2 (CK2) Peptide for Cancer Targeted Therapy
Silvio E. Perea et al, 2015, Protein Kinase CK2 Cellular Function in Normal and Disease States CrossRef - Upregulation of IGF2R evades lysosomal dysfunction-induced apoptosis of cervical cancer cells via transport of cathepsins
Takashi Takeda et al, 2019, Cell Death & Disease CrossRef - The Combination of the CIGB-300 Anticancer Peptide and Cisplatin Modulates Proteins Related to Cell Survival, DNA Repair and Metastasis in a Lung Cancer Cell Line Model
Arielis Rodríguez-Ulloa et al, 2019, Current Proteomics CrossRef - CX-4945 and siRNA-Mediated Knockdown of CK2 Improves Cisplatin Response in HPV(+) and HPV(−) HNSCC Cell Lines
Janeen H. Trembley et al, 2021, Biomedicines CrossRef - CK2 in Cancer: Cellular and Biochemical Mechanisms and Potential Therapeutic Target
Melissa Chua et al, 2017, Pharmaceuticals CrossRef - Role of protein kinase CK2 in antitumor drug resistance
Christian Borgo et al, 2019, Journal of Experimental & Clinical Cancer Research CrossRef - Chimeric peptides as modulators of CK2-dependent signaling: Mechanism of action and off-target effects
Sofia Zanin et al, 2015, Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics CrossRef - Molecular Pathways: Emergence of Protein Kinase CK2 (CSNK2) as a Potential Target to Inhibit Survival and DNA Damage Response and Repair Pathways in Cancer Cells
Adam J. Rabalski et al, 2016, Clinical Cancer Research CrossRef - Protein kinase CK2 – diverse roles in cancer cell biology and therapeutic promise
Janeen H. Trembley et al, 2023, Molecular and Cellular Biochemistry CrossRef - Flavones and flavonols may have clinical potential as CK2 inhibitors in cancer therapy
Mark F. McCarty et al, 2020, Medical Hypotheses CrossRef - Cryptotanshinone inhibits lung tumor growth by increasing CD4+ T cell cytotoxicity through activation of the JAK2/STAT4 pathway
Yonghong Man et al, 2016, Oncology Letters CrossRef - CIGB-300: A peptide-based drug that impairs the Protein Kinase CK2-mediated phosphorylation
Silvio E. Perea et al, 2018, Seminars in Oncology CrossRef - CIGB-300 Peptide Targets the CK2 Phospho-Acceptor Domain on Human Papillomavirus E7 and Disrupts the Retinoblastoma (RB) Complex in Cervical Cancer Cells
Ailyn C. Ramón et al, 2022, Viruses CrossRef - Molecules that target nucleophosmin for cancer treatment: an update
Adele Di Matteo et al, 2016, Oncotarget CrossRef - Nucleophosmin, a multifunctional nucleolar organizer with a role in DNA repair
David J. López et al, 2020, Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics CrossRef - Phosphoproteomic Landscape of AML Cells Treated with the ATP-Competitive CK2 Inhibitor CX-4945
Mauro Rosales et al, 2021, Cells CrossRef - CEP131 indicates poor prognosis and promotes cell proliferation and migration in hepatocellular carcinoma
Xu-Hui Liu et al, 2017, The International Journal of Biochemistry & Cell Biology CrossRef - Targeting of Protein Kinase CK2 Elicits Antiviral Activity on Bovine Coronavirus Infection
Ailyn C. Ramón et al, 2022, Viruses CrossRef - Optimizing CIGB-300 intralesional delivery in locally advanced cervical cancer
null null et al, 2015, British Journal of Cancer CrossRef - Casein kinases as potential therapeutic targets
Giorgio Cozza et al, 2016, Expert Opinion on Therapeutic Targets CrossRef